En Es
Categories

Industry News


Stago Connect.One Network Allows Remote Monitoring of Analyzers

By Labmedica International staff writers
09 Aug 2018

Image: The Connect.One network architecture allows labs to remotely monitor automated analyzers (Photo courtesy of Diagnostica Stago).Diagnostica Stago (Paris, France), an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers.

Stago offers laboratories advanced testing systems and services with specialization in hemostasis and hemostasis systems, in-vitro diagnostics, routine and specialty reagents, and research products. Digitization has revolutionized connectivity by increasing productivity and improving lab efficiency. Today, with connected devices, technical teams are no longer required to remain in front of their workstations, or even in the laboratory.

Stago’s Connect.One checks if automated analyzers in laboratories are operating correctly and diagnoses and analyzes any malfunctions as part of a proactive approach. Systems connected to Connect.One can send QC results to MyExpertQC (Stago’s externalized IQC platform), as well as activity statistics to simplify the management of “Cost Per Reportable Results” contracts. Connect.One can track analyzer performance and send notifications in case of problems while downloading software improvements from a secure infrastructure.

Connect.One is designed to meet international data privacy and security guidelines, and is expected to become a “cornerstone” for integrating new applications. By using their connected devices, laboratories can increase productivity, efficiency and operational flexibility.



E-mail Print
FaceBook Twitter Google+ Linked in

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
Gold member
More info

More articles about DIAGNOSTICA STAGO

30 May 2017
Stago Group Acquires HemoSonics
The Stago Group, which develops and markets automated systems for blood analysis in coagulation, has completed the acquisition of HemoSonics LLC, a developer of point-of-care (POC) testing solutions.
Read More

Additional news

10 Aug 2018
Global Medical Robots Market to Reach USD 16 Billion by 2023
The global medical robots market is projected to grow at a CAGR of 21.0% from an estimated USD 6.46 billion in 2018 to USD 16.74 billion by 2023, driven by technological advancements, advantages of robot-assisted training in rehabilitation therapy, increased funding for medical robot research, and IPOs issued by medical robot companies. However, safety concerns over robotic surgery devices are expected to limit the market growth to some extent. Recent studies have found a number of technical difficulties and complications experienced while performing procedures using robotic systems. According to the FDA, from 2000 to 2013, surgical robots have been linked to over 144 deaths, over 1,391 injuries, and 8,061 device malfunctions.
Read More
10 Aug 2018
Deep Learning-Based System Detects Lesions in Knee MR Images
Researchers from the department of radiology at the University of Wisconsin School of Medicine and Public Health have developed a deep learning approach to detect cartilage lesions by evaluating MR images of the knee. The researchers used segmentation and classification convolutional neural networks (CNNs) to develop the fully automated deep learning–based cartilage lesion detection system.
Read More
10 Aug 2018
New AI Software Cuts Radiation Therapy Planning Time
Researchers from the University of Toronto have developed automation software that will cut down the time for developing radiation therapy plans — individualized maps that help doctors determine where to blast tumors — from days to mere hours.
Read More
10 Aug 2018
RSNA Announces AI and Machine-Learning Initiatives for 2018
The Radiological Society of North America has planned a diverse roster of machine learning (ML) and artificial intelligence (AI) programming for RSNA 2018 that will focus on the power and potential of AI in radiology and issues associated with implementation.
Read More
10 Aug 2018
Global Market for Machine Learning to Surpass USD 2 Billion by 2023
The global market for machine learning in medical imaging is expected to record a robust growth and surpass USD 2 billion by 2023, driven by benefits such as enhanced productivity, increased diagnostic accuracy, more personalized treatment planning and improved clinical outcomes. However, the market is still in the innovator and early adopter phase, and will need to overcome several barriers before AI becomes mainstream in medical imaging. These are the latest findings of Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry.
Read More
31 Jul 2018
DIAsource Immunoassays Enters Agreement with ZenTech for RIA Products
DIAsource Immunoassays, a BioVendor group company, has entered into a strategic agreement with ZenTech under which ZenTech will transfer its portfolio of radioimmunoassays (RIA) products to DIAsource, securing their continued production and sales.
Read More
31 Jul 2018
Report Shows Micro-Machined Ultrasound Transducers Market Growing
Micro-machined ultrasonic transducers (MUTs), in the form of PMUTs (Piezoelectric micro-machined ultrasonic transducers) and CMUTs (capacitive micro-machined ultrasonic transducers), are finally coming to market. New applications, along with improved manufacturing capabilities and advanced technological readiness, are driving the impressive growth of MUTs.
Read More
31 Jul 2018
Machine-Learning Algorithm Analyzes Images to Identify Schizophrenia Patients
A team of researchers from the University of Alberta has developed a machine-learning algorithm to examine functional magnetic resonance imaging (fMRI) images for identifying patients suffering from schizophrenia and ascertaining if they would respond to treatment. In a study, the algorithm examined MRI images of both newly diagnosed, previously untreated schizophrenia patients and healthy subjects and successfully identified patients with schizophrenia at 78% accuracy. It also predicted whether or not a patient would respond positively to a specific antipsychotic treatment named risperidone with 82% accuracy.
Read More
26 Jul 2018
NIH Releases Huge Database of CT Images for AI Testing
The National Institutes of Health’s Clinical Center has made a large-scale dataset of CT images available to the public in order to help the scientific community improve the detection accuracy of lesions. The dataset, named DeepLesion, has over 32,000 annotated lesions identified in CT images, as compared to less than a thousand lesions in most of the publicly available medical image datasets. The images are of 4,400 unique patients, who are partners in research at the NIH and have been completely anonymized. In 2017, the NIH clinical center had released anonymized chest X-ray images and their corresponding data.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions